Extended, but So What?<br />By Rev Shark<br />RealMoney.com Contributor<br />7/27/2009 8:28 AM EDT <br /><br />Our dilemma is that we hate change and love it at the same time; what we really want is for things to remain the same but get better. <br />-- Sydney J. Harris<br /><br />A market as strong as this one has been over the last two weeks presents a difficult dilemma. By almost every technical measure, we are extended and/or overbought. It is reported that the "stocks only" McClellan Oscillator is at the most overbought level ever recorded. A number of other readings like this are out there, but it doesn't take any complicated indicators to know that this market went up a whole lot very fast. <br /><br />The challenge for investors is that extended markets don't necessarily reverse and go straight back down. An old adage says that overbought markets can become even more overbought. There is no way to accurate predict when momentum will slow. <br /><br />To complicate matters further, an extended market can work off its excesses simply by sitting there and doing nothing. We don't have to fall suddenly and sharply for the market to become less extended. We just need to tread water for a little while. <br /><br />On Friday we saw a particularly good example of how a strong, extended market can stay sticky to the upside. This market has been so surprisingly strong that it has left a large contingent of folks underinvested and poorly positioned. They are frustrated and want to add long exposure, but they aren't inclined to chase things in to the stratosphere. However, they would be happy to buy a pullback, and it doesn't take more than a few downticks to make them jump in. <br /><br />So that is where we stand as we kick off the final week of July. The market has extremely strong momentum and lots of underlying support, but is very extended and in need of a rest. <br /><br />So how do we deal with this? If you tried to aggressively short into this action, you had your head handed to you. As I stated, we have no reason to think that we will suddenly reverse downward. If you are loading up on the short side, the danger of a further squeeze and more frustration remain quite high. <br /><br />On the other hand, if you are looking to add some long exposure you aren't going to find much that is set up well technically. A tremendous number of stocks have been up many days in a row and aren't offering easy entry points. The smart move recently has been to chase strength, but for those with a disciplined trading methodology, that is not easy to do -- especially after running straight up for 10 days or so. <br /><br />My inclination at this point is to continue to give the benefit of doubt to the bulls until there is good reason not to. Being extended isn't a sufficient reason to be aggressively short, and there are still some long buys to be found. It isn't easy to find things that are still within a base, but they are out there, and I'm going to focus on those. <br /><br />I suspect this market will work off its overbought conditions by churning and maybe with some mild pullbacks. I don't expect to see a major collapse unless there is some really surprising economic news. Even then, the dip-buyers will be swarming about for a while and won't be discouraged until they suffer some disappointments. <br /><br />It isn't an easy market situation, but if it were easy, it wouldn't be so potentially lucrative. <br />-----------------------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: COT +10.0%, NTY +7.2%, CYOU +4.4%, SOHU +2.9% (light volume)... Select oil/gas related names ticking higher: BP +1.4%, E +1.4%, RDS.A +1.2%... Select solar names showing continued strength: TAN +5.4%, YGE +3.5% (Cramer makes positive comments on MadMoney), JASO +3.4%, STP +2.0% (Cramer makes positive comments on MadMoney), CSIQ +1.9%, LDK +1.7%... Select drug and infectious disease related names trading higher: ACAD +22.6% (continued strength from Friday's 40%+surge higher), NVAX +10.9%, ONCY +10.4% (light volume, successfully completes 100-Litre cGMP Production of REOLYSIN), VICL +9.7%, INCY +6.0%, BCRX +4.8%, SVM +4.2%... Select metals/mining names showing modest strength: GG +1.6%, MT +1.6% (Arcelor Mittal ponders $3 bln stainless steel spinoff - FT), GOLD +1.6%, BBL +1.4%, RTP +1.0%... Other news: RFMD +5.2% (continued strength from Friday's 10% jump), LVS +4.0% (still checking for anything specific), SBUX +1.7% (Cramer makes positive comments on MadMoney), ABT +0.8% (Abbott Labs and Medtronic Resolve Global Vascular Patent Disputes)... Analyst comments: BEAV +6.2% (upgraded to Outperform at FBR Capital), LYG +5.1% (upgraded to Buy at Nomura). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: CALM -10.4%, AET -7.7%, RYAAY -6.0%, PPD -4.8% (light volume), GLW -4.7%, HON -2.6%, ANR -2.0%... M&A news: FNFG -4.2% (First Niagara has agreed to acquire Harleysville National for ~$5.50 per share)... Other news: KV.A -25.5% (disclosed certain information related to current status of the SEC filings, previously disclosed govt investigations and liquidity position), PXP -11.9% (announces an update on its Tranquillon Ridge project), MYL -5.8% (workers overrode drug quality controls - Pittsburgh Post-Gazette), ACI -4.6% (commenced a 17 mln share common stock offering pursuant to an automatic shelf registration statement), HUM -4.5% and WLP -1.7% (down in sympathy with AET), C -1.8% (announces preliminary results of public share exchange)... Analyst comments: ADSK -2.6% (downgraded to Hold at Deutsche), AZN -1.7% (downgraded to Neutral from Outperform at Exane BNP Paribas), BA -0.9% (downgraded to Equal Weight at Barclays).